August Tariff Increases Hit Array of Goods—From Coffee to Pharmaceuticals
Our Privacy Policy has been updated! The Conference Board uses cookies to improve our website, enhance your experience, and deliver relevant messages and offers about our products. Detailed information on the use of cookies on this site is provided in our cookie policy. For more information on how The Conference Board collects and uses personal data, please visit our privacy policy. By continuing to use this Site or by clicking "ACCEPT", you acknowledge our privacy policy and consent to the use of cookies. 

Navigating Washington: Insights for Business

Global Economy Briefs

Timely insights from the Economy, Strategy & Finance Center

August Tariff Increases Hit Array of Goods—From Coffee to Pharmaceuticals

August 06, 2025

US consumers and companies will face higher prices in the months ahead, as the Administration levels up tariffs from its baseline of 10%. Ahead of last week’s tariff deadline, the Administration announced new frameworks via Executive Orders.

The US now has an effective tariff rate of about 18%, the highest since the 1930s. Significant tariff increases include imported goods from the following countries, effective August 7:

  • Brazil: A 50% tariff will mean higher coffee prices. The US imports a third of its coffee from Brazil.
  • Switzerland: A 39% tariff will impact watches, chocolate, and coffee prices.
  • India: A 25% tariff rate on India will impact generic drugs and active pharmaceutical ingredients—leading US imports from India.
  • European Union: At a tariff rate of 15%, goods from the EU are lower than many other trading partners. However, pharmaceuticals aren’t exempted from the agreement. About three-quarters of the US’s $212 billion of imported drugs come from the EU.
  • China: A 30% baseline tariff rate continues. China’s on a separate timeline for t

Author

This publication is available to you, but you need to sign in to myTCB® or create an account to access it.

myTCB® Members get exclusive access to webcasts, publications, data and analysis, plus discounts to events.

More From This Series

Publications



Press Releases / In the News